Sign in

CIK 0001604464

  • Non-accelerated filer
  • Smaller reporting company

Atara Biotherapeutics, Inc.

Sign in to watch
Ticker
ATRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460920988
Phone
+1 805-623-4211
Business address
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
Open-market buys, last 90 days
$999,994
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$999,994. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Cherry Brian N +$1000K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-06-07 Koppikar Utpal Chief Financial Officer Grant or award +45,000 45,000
2018-06-07 Koppikar Utpal Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +75,000 75,000
2018-06-06 Ciechanover Isaac E. Chief Executive Officer Sale −1,900 $46.53 $88K 164,978
2018-06-06 Ciechanover Isaac E. Chief Executive Officer Sale −1,500 $47.69 $72K 163,478
2018-06-06 Ciechanover Isaac E. Chief Executive Officer Sale −1,000 $48.59 $49K 162,478
2018-06-05 Ciechanover Isaac E. Chief Executive Officer Sale −3,200 $49.51 $158K 168,078
2018-06-05 Ciechanover Isaac E. Chief Executive Officer Sale −1,200 $50.27 $60K 166,878
2018-05-22 Ciechanover Isaac E. Chief Executive Officer Sale −4,400 $50.88 $224K 171,278
2018-05-21 Ciechanover Isaac E. Chief Executive Officer Sale −1,500 $51.67 $78K 178,578
2018-05-21 Ciechanover Isaac E. Chief Executive Officer Sale −2,000 $52.83 $106K 176,578
2018-05-21 Ciechanover Isaac E. Chief Executive Officer Sale −900 $53.64 $48K 175,678
2018-05-18 Clark Mitchall G. EVP & Chief R & QA Officer Sale −25,860 $50.03 $1.3M 107,972
2018-05-16 Clark Mitchall G. EVP & Chief R & QA Officer Sale −4,347 $46.04 $200K 134,132
2018-05-16 Clark Mitchall G. EVP & Chief R & QA Officer Sale −300 $46.30 $14K 133,832
2018-05-16 Gallagher Carol Giltner Director Sale −273 $46.06 $13K 111,192
2018-05-15 Porter Derrell SVP, Head of Global Commercial Option exercise +16,334 $14.30 $234K 28,834
2018-05-15 Porter Derrell SVP, Head of Global Commercial Sale −16,334 $45.02 $735K 12,500
2018-05-15 Porter Derrell SVP, Head of Global Commercial Option exercise · Employee Stock Option (Right to Buy) −16,334 113,666
2018-05-15 Fust Matthew K Director Option exercise +534 20,354
2018-05-15 Fust Matthew K Director Option exercise · Restricted Stock Units −534 0

Page 30 of 44 · 867 trades